Non Small Cell Lung Cancer | Lung Adenocarcinoma | Small Cell Lung Cancer | |
---|---|---|---|
icotinib | |||
erlotinib + ramucirumab | |||
gefitinib | |||
erlotinib | |||
dacomitinib | |||
aumolertinib | |||
erlotinib + anlotinib | |||
afatinib | |||
durvalumab | |||
FCN-411 | |||
pembrolizumab | |||
osimertinib | |||
PD-L1 inhibitor | |||
EGFR inhibitor | |||
Tyrosine kinase inhibitor | |||
bevacizumab + osimertinib | |||
PD1 inhibitor |